FDA Commissioner Scott Gottlieb spelled out his intentions in a blog post published on Monday, saying the complex nature of some drugs - such as metered dose inhalers and some injectables - had ...

Relvar Ellipta is a once-daily dual combination treatment comprising fluticasone furoate, an inhaled corticosteroid and vilanterol, a long-acting beta2-agonist, in a single inhaler, the Ellipta.